Pharma IPR Conference
February 15, 2024, 6:43 PM
Axinn is proud to be a Platinum Partner of the Pharma IPR Conference
- On March 5 at 11:00 AM, partners Aziz Burgy, Ted Mathias, and counsel Rebecca Clegg are excited to conduct a panel discussion covering “Polymorph Patents: Infringement and Invalidity Challenges.”
We Know Pharma … and They Know Us
Axinn is the go-to firm for IP matters of strategic importance and offers one of the leading pharmaceutical practices in the country. Our team combines its depth of substantive patent law and litigation experience with FDA and antitrust knowledge to offer clients a unique and holistic offering. Whether leading a patent trial on a blockbuster product or navigating the complex FDA regulatory regime, Axinn enables pharmaceutical clients to bring their products to market in the most profitable manner possible.
We've worked on some of the most successful products in the pharmaceutical industry representing over $30 billion in annual sales, including:

Extensive Pharmaceutical Industry Experience

Contact Us
Please reach out to any of our attorneys attending the conference. You can set up a time to meet with an individual attorney using the email link in their contact details.
| Aziz Burgy Partner aburgy@axinn.com | Rebecca Clegg Counsel rclegg@axinn.com | ||
| Ted Mathias Partner tmathias@axinn.com |

To subscribe to our publications, click here.
Tags
News & Insights
News & Insights
The Empty Chair in Antitrust Conspiracy Cases
Webinar
Antitrust
USC Gould/Analysis Group Global Competition Law Thought Leadership Conference
Speaking Engagement
Antitrust
17th ACI Summit on Biosimilars & Innovator Biologics
Speaking Engagement
Intellectual Property
GCR Live: Europe 2026
Speaking Engagement
Antitrust
20th Annual IBA Competition Mid-Year Conference
Speaking Engagement
Antitrust
Axinn Partners Named to Lawdragon 500 Leading Global Litigators 2026
News
Litigation & Trials
Turning Up the Heat: Federal Circuit Sets the Temperature for pH Measurements in Precedential Opinion
Axinn Viewpoints
Intellectual Property
Axinn Represents Tecomet in Closing of Merger with Orchid Orthopedic
Deals & Cases
Antitrust
Recent Benchmarking Suits Highlight DOJ Enforcement Risks
Byline Articles
Antitrust
“Old Crime, New Code” – DOJ Outlines its Views on When Software and AI Can Facilitate Collusion
Axinn Viewpoints
Antitrust